China’s NMPA and CNIPA Propose Draft Measures on Patent Linkage for Public Comment: Implications for the Future of Innovative and Generic DrugsBy: Susie Cheng, Ph.Don October 20, 2020 at 11:15 am Publication: IPWatchdog.com | Patents & Patent Law

The National Medical Products Administration (NMPA), in conjunction with the China National Intellectual Property Administration (CNIPA), recently solicited public comments on the draft of “Measures For the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial)” (  Read More>>

Categories   China, Government, Guest Contributors, International, IP News, IPWatchdog Articles, Legislation, Patents, China National Intellectual Property Administration, drug patents, generic drugs, Guest Contributor, intellectual property, legislation, National Medical Products Administration, patent, patent linkage